Weight loss drug 'Ozempic' approved in India: Uses, benefits, and side effects explained
Published on: Oct. 3, 2025, 5:26 p.m. | Source: The Economic Times
India has officially approved the use of Ozempic (semaglutide), a once-a-week injectable drug for adults with type 2 diabetes. The approval, granted by the Central Drugs Standard Control Organisation (CDSCO), marks a significant milestone for Indian healthcare. Globally, Ozempic has gained attention not only for its effectiveness in controlling diabetes but also for its role in supporting weight loss. With India facing one of the world’s largest diabetes burdens, the arrival of this drug could influence treatment choices and lifestyle changes for millions of patients. Ozempic approval in India
